Why do we need this research?
Diabetes diagnosed during pregnancy is known as gestational diabetes. It can increase the risk of pre-eclampsia, large babies and problems like obstructed labour, where the baby is not able to leave the womb during birth. Gestational diabetes is also becoming more common, making it even more important that we find ways to treat it.
What’s happening in this project?
There is growing evidence that the contents of our guts can influence the risk of diseases, including diabetes. This includes both chemicals produced by our own bodies, and bacteria that live in our guts. Certain substances in the gut can make the body release hormones, and in turn changes the way the body reacts to things like sugar and cholesterol. These gut hormones may also affect the risk of developing diabetes during pregnancy.
In this study, our researchers will ask pregnant women with diabetes to eat a special diet, designed by a dietician, for one day. During the day, the team will take timed blood samples to measure gut hormones released into the blood. They will also collect stool samples to look at the bacteria and chemicals in the gut that might be causing the release of these hormones.
The team want to see if they can change which hormones are released into the gut, and if this could treat gestational diabetes. To find out the best way of doing this, the team will give women either metformin, a drug currently used to treat gestational diabetes, or UDCA, a drug which is currently used to treat intrahepatic cholestasis of pregnancy. Our researchers have already found that UDCA could be more effective than metformin in treating gestational diabetes, and that this might be because of how UDCA is processed in the gut.
What difference will this project make?
The results of this research will help us to find safe, effective ways of controlling diabetes during pregnancy. This means we can help more women to have healthy babies without complications.
Get our research updates
Tommy’s funds research across the UK investigating the reasons for pregnancy complications and loss. We can keep you updated on our research news. If you're interested in being kept updated about our research and news from Tommy's, click here.
More research projects
Miscarriage and ectopic pregnancy may trigger long-term post-traumatic stress, anxiety and depression
The largest ever study into the psychological impact of miscarriage and ectopic pregnancy has shown that early-stage pregnancy loss can have a serious impact on mental health. The research was led by Professor Tom Bourne at the Tommy’s National Centre for Miscarriage Research at Imperial College London.
A pilot trial led by Tommy’s National Centre for Miscarriage Research suggests diabetes drug could be repurposed to target the lining of the womb in women with recurrent miscarriage.
More than a third of maternity doctors admitted they suffer from burnout and exhaustion. This means that they may avoid difficult cases, over-prescribe medications and care less about their patients, increasing the risk of mistakes.
Abdominal stitch is more effective than vaginal stitch for women who experience recurrent preterm births
A clinical trial has shown that an abdominal stitch can save babies’ lives by reducing preterm birth for high-risk women who have had a previous failed vaginal stitch. The trial was led and co-authored by Professor Andrew Shennan, Clinical Director of Tommy’s Preterm Surveillance Clinic.